cognitive cybersecurity intelligence

News and Analysis


Why Canada must amend the Controlled Drugs and Substances Act

Beginning in seven months, the new federal legislation will make Canadians with some mental illnesses, including treatment-resistant depression, eligible for medical assistance in dying (MAiD). However, the government is urged to consider amending the Controlled Drugs and Substances Act to allow psychedelic-assisted therapies, such as psilocybin therapy, which has shown promising results in treating mental illnesses.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts